We are happy to announce the new International Law Talk Podcast episode on EU competition law developments in the pharmaceutical sector. And this one is twice as good! Not only are we discussing both competition and IP issues, but I also interviewed two leading experts in the field: Michael Clancy and David Hull from Van Bael & Bellis.
In the podcast, we touch upon new pharma developments regarding the Covid IP waivers, patent settlements, patent late life cycle strategies, biosimilars, excessive pricing, merger control and much more. Listen to the podcast!
In case you want to learn more on competition law and pharma, the new edition of the book by Van Bael & Bellis on Competition Law of the European Union has a great new section on the topic.
________________________
To make sure you do not miss out on regular updates from the Kluwer Competition Law Blog, please subscribe here.
